Journal of drug targeting · 2024 · 10 citations · 92 references
MedicineCancer BiologyOncologyCarcinogenesisChemotherapyMolecular OncologyBioactive Natural ProductsCancer ChemopreventionMalignant NeoplasmsRadiation CarcinogenesisRadiation TherapyRadiation-induced Cell DeathAnticancer ActivityAnticancer Natural ProductsBioactive Plant CompoundsCancer Cell Proliferation InhibitionCell Division ControlPlant-based TherapeuticsPlant-derived Natural ProductsUltraviolet Radiation-induced Carcinogenesis
Various cells in our body regularly divide to replace old cells and dead cells. For a living cell to be growing, cell division and differentiation is highly essential. Cancer is characterised by uncontrollable cell division and invasion of other tissues due to dysregulation in the cell cycle. An accumulation of genetic changes or mutations develops through different physical (UV and other radiations), chemical (chewing and smoking of tobacco, chemical pollutants/mutagens), biological (viruses) and hereditary factors that can lead to cancer. Now, cancer is considered as a major death-causing factor worldwide. Due to advancements in technology, treatment like chemotherapy, radiation therapy, bone marrow transplant, immunotherapy, hormone therapy and many more in the rows. Although, it also has some side effects like fatigue, hair fall, anaemia, nausea and vomiting, constipation. Modern improved drug therapies come with severe side effects. There is need for safer, more effective, low-cost treatment with lesser side-effects. Biologically active natural products derived from plants are the emerging strategy to deal with cancer proliferation. Moreover, they possess anti-carcinogenic, anti-proliferative and anti-mutagenic properties with reduced side effects. They also detoxify and remove reactive substances formed by carcinogenic agents. In this article, we discuss different plant-based products and their mechanism of action against cancer.
92
Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations
Medicine, Oncology, Pharmacology +10
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Roman Rouzier, Charles M. Perou, W. Fraser Symmans et al. · Clinical Cancer Research · 2005 · 1.9K citations · Full text
Medicine, Cancer Biology, Oncology +17
How Taxol/paclitaxel kills cancer cells
Beth A. Weaver · Molecular Biology of the Cell · 2014 · 1.6K citations
Medicine, Oncology, Pharmacology +13
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Navneet K. Dhillon, Bharat B. Aggarwal, Robert A. Newman et al. · Clinical Cancer Research · 2008 · 1.3K citations
Medicine, Oncology, Pharmacology +15